Search results
ALMS Surges as Envudeucitinib Meets Goals in Plaque Psoriasis Studies
Shares of Alumis ALMS surged 95.3% on Jan. 6, after the company announced positive top-line data from its two phase III studies — ONWARD1 and ONWARD2 — which evaluated its pipeline candidate
PFG or PUK: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Insurance - Multi line sector might want to consider either Principal Financial (PFG) or Prudential (PUK). But which of these two stocks presents investors with
Time for China ETFs Now?
Concerns over China’s economic challenges have been rife in recent years. The Chinese economy grew at its slowest annual pace in a year during the July-September quarter, growing 4.8%, in line with
Apogee Misses Earnings Estimates in Q3, Lowers FY26 EPS Outlook
Apogee Enterprises, Inc. APOG reported adjusted earnings per share (EPS) of $1.02 for third-quarter fiscal 2026, missing the Zacks Consensus Estimate of $1.03 per share. The bottom line decreased
The Bottom Line: Grönland-Gespräche, US-Inflationsdaten und deutsche BIP-Zahlen
In der kommenden Woche stehen die Gespräche zwischen den USA und Dänemark über Grönland im Mittelpunkt. Die strategische Bedeutung der Insel und ihre Rohstoffvorkommen rücken sie ins Zentrum
Service Corporation Revenue Mix: What's Powering the Top Line?
Service Corporation International SCI reported third-quarter 2025 revenue of $1.06 billion, up 4.4% from the prior-year quarter. The increase reflects how the company’s revenue mix is evolving
AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations
Amarin’s AMRN shares surged nearly 17% following the release of preliminary sales numbers for fourth-quarter and full-year 2025, which exceeded expectations.
Amarin’s top line currently comprises
TD SYNNEX Q4 Earnings Beat Estimates, Revenues Increase Y/Y
TD SYNNEX SNX reported non-GAAP earnings of $3.83 per share for the fourth quarter of fiscal 2025, which beat the Zacks Consensus Estimate by 4.1%. The bottom line increased 24% year over year.
Neogen's Q2 Earnings and Revenues Beat Estimates, Stock Climbs
Neogen Corporation NEOG reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of 10 cents, which topped the Zacks Consensus Estimate by 42.86%. However, the bottom line compares
J.M. Smucker's Pet Food Sales Soft: Is Demand Normalizing Yet?
The J. M. Smucker Company’s SJM U.S. Retail Pet Foods segment delivered soft top-line results in the second quarter of fiscal 2026, underscoring ongoing normalization across the category following
Can Estee Lauder's Fragrance Strength Drive Top-Line Growth?
The Estee Lauder Companies Inc. (EL) has pointed to fragrance as a meaningful driver of organic sales growth. In the first quarter of fiscal 2026, fragrance was the company’s strongest-performing
PayPal's Agentic Commerce Expansion: Will it Boost Top-Line Growth?
PayPal Holdings PYPL announced a strategic partnership with Microsoft to power the rollout of Copilot Checkout in Copilot. This enables shoppers to discover, decide and pay entirely within the
Lindsay Q1 Earnings Beat Estimates, Revenues Decrease 6% Y/Y
Lindsay Corporation LNN delivered earnings per share of $1.54 in first-quarter fiscal 2026 (ended Nov. 30, 2025), beating the Zacks Consensus Estimate of $1.46. The bottom line decreased 2% year
TEM's Collab for Oncology Patient Population Is Gaining Attention
Tempus AI TEM recently started working with leading academic medical centers to broaden access to advanced genomic testing and data-driven cancer care. In line with this, Tempus and NYU Langone
Will AbbVie's Oncology Segment Support Top-line Growth in Q4 Earnings?
A meaningful portion of AbbVie’s ABBV revenues comes from its oncology franchise. Initially anchored by blood cancer drugs Imbruvica and Venclexta, the company has expanded its offerings into solid
3 Cruise Line Stocks in Focus on Expected Demand Strength in 2026
The cruise industry is benefiting from strong demand for cruising and increased booking volumes. The industry is benefiting from solid bookings concerning North American and European sailings. Also
MKL Stock Trading at a Discount to Industry at 1.48X: Time to Hold?
Markel Group Inc. MKL shares are trading at a discount compared with the Zacks Insurance - Multi-line industry. Its price-to-book ratio of 1.48X is lower than the industry average of 2.71X, the Fina



